Male Stress Urinary Incontinence Market
Report ID: SQMIG35A4022
Report ID: SQMIG35A4022
[email protected]
USA +1 351-333-4748
Report ID:
SQMIG35A4022 |
Region:
Global |
Published Date: June, 2026
Pages:
157
|Tables:
171
|Figures:
79
Global Male Stress Urinary Incontinence Market size was valued at USD 642.8 Million in 2024 and is poised to grow from USD 687.15 Million in 2025 to USD 1171.86 Million by 2033, growing at a CAGR of 6.9% during the forecast period (2026-2033).
Global Male Stress Urinary Incontinence (SUI) Market Overview The male stress urinary incontinence (SUI) market comprises products and services for treating urine leakage during activities such as coughing, lifting, or exercising that increase abdominal pressure. This is important because it can improve the quality of life of men who have had prostate surgery, neurological disorders or a weak pelvic floor. The market traces its roots to sales of catheter and absorbent products in the late 1990s, but growth was kicked into gear with the introduction of male-specific continence pads and urethral bulking agents in the 2010s. This evolution is due to increasing awareness, surgical volume and a demographic shift to an older male population requiring solutions.
Market growth is driven by the arrival of minimally invasive devices. Male slings, artificial urinary sphincters and injectable bulking agents provide durable continence with fewer postoperative complications. For example, a 2022 multicenter trial demonstrated that a polypropylene sling reduced episodes of leakage by 78% and hospitalization to 2 days, leading urologists to favor it over AUS implantation. This profile is critical to getting reimbursement approvals in Europe and North America, which in turn helps attract investment from medical-device companies that want to access a growing patient base of prostatectomy survivors. The market is therefore expected to grow significantly at a rate of over eight percent through 2032.
How is AI-driven diagnostic automation shaping the male stress urinary incontinence market?
Urodynamic testing, wearable sensors and machine learning algorithms are tools that allow better evaluation of male stress urinary incontinence and automated diagnosis. They rapidly recognize patterns of leakage and levels of gravity and suggest individual treatment routes. Clinicians can make decisions more quickly and spend less time doing manual chart review Patients are treated in a less invasive way and they recover. This also enables remote monitoring of the system and thus continuous data collection which improves predictive models and provides better long term results. Healthcare systems are driven by efficiency and outcome based care. AI diagnostics are a key component in the modern management of incontinence.
For example, Boston Scientific launched new AI-enabled diagnostic platform in August 2024 that uses real-time pressure mapping and automated reporting to speed up patient triage and allow for targeted device selection, which will support market growth and operational improvements.
Market snapshot - (2026-2033)
Global Market Size
USD 642.8 Million
Largest Segment
Fastest Growth
Growth Rate
6.9% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global male stress urinary incontinence market is segmented by treatment type, disease severity, treatment setting, end user, patient age group, distribution channel and region. Based on treatment type, the market is segmented into Male Sling Systems, Artificial Urinary Sphincters, Pharmacological Therapy and Others. Based on disease severity, the market is segmented into Mild Incontinence, Moderate Incontinence and Severe Incontinence. Based on treatment setting, the market is segmented into Surgical Treatment and Non-Surgical Treatment. Based on end user, the market is segmented into Hospitals, Urology Clinics, Ambulatory Surgical Centers and Others. Based on patient age group, the market is segmented into Adult Patients and Geriatric Patients. Based on distribution channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
The surgical treatment segment is dominating the market owing to the focus of clinicians on long-term solutions to regain continence with lower recurrence. Sling procedures and artificial urinary sphincters are very effective and urologists are confident and consistent in their use across care pathways. Patients looking for definite results are more likely to listen to their providers, which creates a feedback loop that keeps demand going. Reimbursement schemes also favor procedural interventions, further cementing its market leadership and hospital capital investment plans for advanced surgical suites.
The conservative treatment segment is experiencing the highest growth momentum due to patients’ preference for non-invasive options with fewer complications. There is increasing evidence for pelvic floor therapy and pharmacological regimens, and telehealth platforms are increasing access to specialist advice. That growing acceptance is helping to stimulate market growth and new product innovation opportunities across the sector worldwide.
The mild severity segment accounts for the largest share as early-stage patients prefer discreet management methods to maintain their quality of life and avoid surgical intervention. These expectations are met by absorbent devices that fit into one’s lifestyle and behavioral therapies that are recommended by clinicians as first-line options. Mild cases tend to be less costly covered by insurance, which promotes use. The convergence of patient demand, clinical guidelines, and payer support drives its market dominance and sustains commercial interest from manufacturers.
Conversely, severe severity segment emerges as the leading high-growth segment as advancements in adjustable artificial urinary sphincters cater to complex leakage patterns. Minimally invasive implantation techniques that are novel reduce peri-operative risk, and thus urologists are motivated to broaden indications. Increasing clinical evidence and patient advocacy for strong solutions are driving the demand and this niche is being positioned as a driver for future market expansion.
To get detailed segments analysis, Request a Free Sample Report
North America is the leading region with a strong healthcare system with advanced services in urology and full insurance coverage, which makes it easier for new therapies to be quickly adopted. Demand is driven by strong physician awareness and patient education programs whereas product innovation and regulatory approvals are driven by collaborative research networks. The region’s cluster of medical device manufacturers and early adoption of new technologies creates a virtuous cycle of market leadership and ongoing investment in therapeutic options.
Male Stress Urinary Incontinence Market in the United States is driven by large clinical experience, wide insurance reimbursement environment and active regulatory environment that allows for quick introduction of new interventions. Patient advocacy groups and education campaigns are building awareness and leading academic centers are creating evidence, which is further bolstering clinician confidence and driving ongoing market growth.
Public health system that prioritizes access to evidence-based treatment is a driver of the male stress urinary incontinence market in Canada. National guidance advises consistent use of approved devices and standard care pathways. Rising patient awareness campaigns are driving the demand for solutions that offer effective management to the population across the country Research collaborations between government agencies and industry are driving research initiatives.
Europe’s growth is supported by harmonized regulatory frameworks that speed up approvals of products across member states and strong networks for clinical research that generate robust efficacy data. With growing public health interest in quality of life issues for aging males and reimbursement policies favouring cost-effective interventions. Strategic alliances between multinational manufacturers and local distributors also propel market growth, by providing extensive geographic reach and tailored product portfolios to address the needs of different healthcare systems.
In Germany, the male stress urinary incontinence market can count on a well-established landscape of urology specialty, anchored by leading research hospitals. There are good insurance schemes which cover new treatments. National guidelines for clinical practice recommend different treatment options. Continuous product refinement through collaborative industry-academic partnerships further cements Germany’s position as the dominant market in the European region.
UK market for male stress urinary incontinence is growing at a faster pace due to proactive NHS initiatives on patient-centric care pathways The emphasis on early diagnosis and integrated multidisciplinary management facilitates the rapid adoption of sophisticated devices. Clinical trials continue to provide an evidence pipeline to build clinician confidence and expand market penetration. Professional societies lobby.
France Male Stress Urinary Incontinence Market is emerging as a promising segment, owing to the national health policies which are increasingly acknowledging the importance of managing male urinary symptoms. Modern therapy solutions are driven by the growing awareness of urologists and patients as well as by positive reimbursement schemes. Emerging research partnerships are positioning France to become a major player in the wider European market.
The Asia Pacific region has an increasing role to play with growing investment in healthcare, specialist networks and consumer awareness around male urinary health. Regional regulatory agencies are expediting approval pathways to facilitate faster time to market for novel devices. The demand is being driven by the rising concern on aging population and lifestyle related diseases. The penetration of the products into different markets is being aided by partnership of global manufacturers with local distributors.
The Japan Male Stress Urinary Incontinence Market is driven by advanced medical infrastructure and emphasis on precision urology and evidence-based practice. The national health insurance provides good coverage for approved interventions and strong physician education programs help to increase awareness of new treatment options. The industry-academic research collaboration strengthens the validation of the product and facilitates the gradual market growth.
Market Dynamics: Rapid Adoption of Innovative Medical Technologies and Favorable Regulatory Environment to Accelerate the Growth of South Korea Male Stress Urinary Incontinence Market Government health programs focus on early detection and comprehensive management of urinary disorders while private insurance plans enhance access to new therapies. The market is expanding owing to the increased clinical expertise and strategic partnerships with multinational corporations. South Korea is the leading country in the region.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Increasing Awareness and Screening
Advances in Minimally Invasive Devices
High Cost of Advanced Therapies
Cultural Stigma Around Male Incontinence
Request Free Customization of this report to help us to meet your business objectives.
That’s good news for the male stress urinary incontinence market as embryonic medtech companies close big funding deals and get FDA clearance to challenge long-established device vendors. Examples of tech-driven entry include Pelvital’s $2.68 million seed round led by Boomerang Ventures and its FDA-cleared Flyte system. A $60 million strategic investment announced in 2026 underscores aggressive M&A and partnership activity among larger players looking to build SUI portfolios.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis the global male stress urinary incontinence market is propelled primarily by increasing awareness and screening, which expands the pool of diagnosed patients and fuels demand for therapies, while advances in minimally invasive devices serve as a second driver by offering effective, low‑recovery options that attract both clinicians and patients. The high cost of advanced therapies acts as a restraint, limiting adoption in price‑sensitive settings. North America dominates the market thanks to its mature healthcare system, robust reimbursement and strong physician adoption, and within this landscape the surgical treatment segment leads consumption, reflecting preference for durable sling and artificial sphincter solutions.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 642.8 Million |
| Market size value in 2033 | USD 1171.86 Million |
| Growth Rate | 6.9% |
| Base year | 2024 |
| Forecast period | (2026-2033) |
| Forecast Unit (Value) | USD Million |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Male Stress Urinary Incontinence Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Male Stress Urinary Incontinence Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Male Stress Urinary Incontinence Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Male Stress Urinary Incontinence Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Male Stress Urinary Incontinence Market size was valued at USD 642.8 Million in 2024 and is poised to grow from USD 687.15 Million in 2025 to USD 1171.86 Million by 2033, growing at a CAGR of 6.9% during the forecast period (2026-2033).
The male stress urinary incontinence market is intensifying as emerging medtech firms secure sizable capital and obtain FDA clearance, directly contesting incumbent device makers. Pelvital’s $2.68 million seed round led by Boomerang Ventures and its FDA‑cleared Flyte system exemplify tech‑driven entry, while a $60 million strategic investment announced in 2026 underscores aggressive M&A and partnership activity among larger players seeking to broaden SUI portfolios. 'Boston Scientific Corporation', 'Coloplast A/S', 'Zephyr Surgical Implants', 'Promedon Group', 'Rigicon, Inc.', 'Uromedica, Inc.', 'Teleflex Incorporated', 'Becton, Dickinson and Company', 'Johnson & Johnson MedTech', 'Medtronic plc', 'Cook Medical LLC', 'Laborie Medical Technologies Corp.', 'SRS Medical Systems, Inc.', 'UroMems SAS', 'Pfizer Inc.', 'AbbVie Inc.', 'Astellas Pharma Inc.', 'Recordati S.p.A.', 'Ferring Pharmaceuticals A/S', 'Veru Inc.'
Growing public education campaigns and physician outreach have increased awareness of male stress urinary incontinence, encouraging men to recognize symptoms early and pursue medical evaluation. This heightened visibility reduces diagnostic delays, expands the pool of patients eligible for treatment, and drives demand for a broader range of therapeutic options, thereby supporting market expansion through increased product adoption and service utilization across diverse healthcare settings. Including both private clinics and public hospitals, the increased patient flow also encourages manufacturers to invest in product innovation and distribution networks, further reinforcing growth momentum.
Innovative Absorbent Technologies: The market is witnessing rapid adoption of next‑generation absorbent cores that combine ultra‑thin structures with high fluid capture efficiency, enabling discreet wear and improved confidence for users. Manufacturers are leveraging advanced polymer science and textile engineering to produce pads that conform to male anatomy, reducing chafing and odor. This shift toward smarter materials is reshaping product positioning, encouraging premium branding, and fostering collaborations with urology specialists to tailor designs that meet lifestyle demands while supporting long‑term adherence and patient satisfaction.
Why does North America Dominate the Global Male Stress Urinary Incontinence Market? |@12
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
